The Hadronic Light-by-Light Contribution to the Muon Anomalous Magnetic Moment: Where do we stand?

We review the status of the hadronic light-by-light contribution to the muon anomalous magnetic moment and critically compare recent calculations. We also study in detail which momentum regions the pi^0 exchange main contribution originates. We also argue that a_\mu^{light-by-light} = (11 \pm 4) \times 10^{-10} encompasses the present understanding of this contribution and comment on some directions to improve on that.Comment: 16 pages, 9 figure

Comparison of Three Schemes of Two-Photon Laser-Induced Fluorescence for CO Detection in Flames.

Two-photon excitation laser-induced fluorescence of carbon monoxide suffers from interference from mainly C and strong pressure quenching. This paper presents an investigation of three excitation/detection schemes for two-photon excitation laser-induced fluorescence on carbon monoxide. The schemes are evaluated for pressure and quenching partner dependencies and C interference. Three different emission bands lie in the Hopefield-Birge system: The Ångström BΣ→AΠ band, with two-photon excitation through BΣ←XΠ around 230 nm; the Herzberg band CΣ→AΠ, with two-photon excitation through, CΣ←XΠ, around 217 nm; and the third positive group bΣ→aΠ, also with excitation of BΣ←XΠ around 230 nm. The measurements are performed in laminar premixed flames with various equivalence ratios as well as in a high-pressure cell, where pressure and species concentrations are varied in order to investigate the fluorescence quenching dependence

Randomised prostate cancer screening trial: 20 year follow-up

Objective To assess whether screening for prostate cancer reduces prostate cancer specific mortality

Experimental infection with high‐ and low‐virulence strains of border disease virus (BDV) in Pyrenean chamois (Rupicapra p. pyrenaica ) sheds light on the epidemiological diversity of the disease

Since 2001, Pyrenean chamois (Rupicapra pyrenaica pyrenaica ) populations have been affected by border disease virus (BDV) causing mortalities of more than 80% in some areas. Field studies carried out in France, Andorra, and Spain have shown different epidemiological scenarios in chamois populations. This study was designed to confirm the presence of BDV strains of a high and low virulence in free‐ranging chamois populations from Pyrenees and to understand the implications of these findings to the diverse epidemiological scenarios. An experimental infection of Pyrenean chamois with a high‐virulence (Cadí‐6) and low‐virulence (Freser‐5) BDV strains was performed. Pregnant and non‐pregnant animals with and without antibodies against BDV were included in each group. Cadí‐6 BDV strain was confirmed to be of high virulence for seronegative adults and their foetuses. The antibody negative chamois infected with Freser‐5 BDV strain did not show symptoms, presented less viral distribution and RNA load in tissues than Cadí‐6 group, and cleared the virus from the serum. However, foetuses died before the end of the experiment and RNA virus was detected in sera and tissues although with lower RNA load than the Cadí‐6 group. Chamois from both groups presented lesions in brain but the ones infected with the low‐virulence Freser‐5 BDV strain were mild and most likely transient. In both groups, seropositive pregnant females and all but one of their foetuses did not present viraemia or viral RNA in tissues. The existence of a low‐virulence strain has been confirmed experimentally and related to chamois population infection dynamics in the area where it was isolated. Such strain may persist in the chamois population through PI animals and may induce cross‐protection in chamois against high‐virulence strains. This study demonstrates that viral strain diversity is a significant factor in the heterogeneity of epidemiological scenarios in Pyrenean chamois populations.info:eu-repo/semantics/acceptedVersio

Multi-species PLIF study of the structures of turbulent premixed methane/air jet flames in the flamelet and thin-reaction zones regimes

Simultaneously planar laser-induced fluorescence (PLIF) measurements of OH, CH, CH2O and toluene are carried out to investigate the structures of turbulent premixed methane/air jet flames in the flamelet regime and the thin-reaction zones regime. A premixed flame jet burner of an inner diameter of 1.5 mm is employed. Stoichiometric methane/air mixtures introduced as a jet are ignited and stabilized in a hot co-flow generated by a coaxial porous plug pilot flame surrounding the jet. The Reynolds number for the studied jet ranges from 960 to 11,500 with the characteristic Karlovitz number ranging from 1 to 60. The focus of this study is on the characterization of the structures and turbulent burning velocity of premixed flames in the flamelet and the thin-reaction zones regimes. The preheat zone is analyzed using the CH2O and toluene PLIF fields, whereas the reaction zone is analyzed using the CH and OH PLIF fields. Laser Doppler Anemometer (LDA) measurements are performed to characterize the turbulence field and it is noted that when the Reynolds/Karlovitz number increases a successive thickening of the preheat zone is observed, whereas the reaction zone, characterized by the CH layer maintains nearly the same thickness. The heat release zone, characterized by the combination of the OH and CH2O PLIF fields, is shown to nearly maintain the same thickness under the present experimental conditions. The flame surface wrinkle ratio is shown to be Reynolds number and Karlovitz number independent when the Reynolds number is high enough such that the smallest wrinkle scales reach to the length scales of the thin reaction layers. The global fuel consumption speed of the jet flame is analyzed using the toluene PLIF field and the OH PLIF field. A discrepancy in the two consumption velocities is found as the Karlovitz number increases. This is found to be a result of the broadening of the oxidation zone. These findings provide experimental support to the flamelet and thin-reaction zone regime hypotheses of turbulent premixed combustion

Effect of Trans-Nasal Evaporative Intra-arrest Cooling on Functional Neurologic Outcome in Out-of-Hospital Cardiac Arrest : The PRINCESS Randomized Clinical Trial

© 2019 American Medical Association. All rights reserved.Importance: Therapeutic hypothermia may increase survival with good neurologic outcome after cardiac arrest. Trans-nasal evaporative cooling is a method used to induce cooling, primarily of the brain, during cardiopulmonary resuscitation (ie, intra-arrest). Objective: To determine whether prehospital trans-nasal evaporative intra-arrest cooling improves survival with good neurologic outcome compared with cooling initiated after hospital arrival. Design, Setting, and Participants: The PRINCESS trial was an investigator-initiated, randomized, clinical, international multicenter study with blinded assessment of the outcome, performed by emergency medical services in 7 European countries from July 2010 to January 2018, with final follow-up on April 29, 2018. In total, 677 patients with bystander-witnessed out-of-hospital cardiac arrest were enrolled. Interventions: Patients were randomly assigned to receive trans-nasal evaporative intra-arrest cooling (n = 343) or standard care (n = 334). Patients admitted to the hospital in both groups received systemic therapeutic hypothermia at 32°C to 34°C for 24 hours. Main Outcomes and Measures: The primary outcome was survival with good neurologic outcome, defined as Cerebral Performance Category (CPC) 1-2, at 90 days. Secondary outcomes were survival at 90 days and time to reach core body temperature less than 34°C. Results: Among the 677 randomized patients (median age, 65 years; 172 [25%] women), 671 completed the trial. Median time to core temperature less than 34°C was 105 minutes in the intervention group vs 182 minutes in the control group (P < .001). The number of patients with CPC 1-2 at 90 days was 56 of 337 (16.6%) in the intervention cooling group vs 45 of 334 (13.5%) in the control group (difference, 3.1% [95% CI, -2.3% to 8.5%]; relative risk [RR], 1.23 [95% CI, 0.86-1.72]; P = .25). In the intervention group, 60 of 337 patients (17.8%) were alive at 90 days vs 52 of 334 (15.6%) in the control group (difference, 2.2% [95% CI, -3.4% to 7.9%]; RR, 1.14 [95% CI, 0.81-1.57]; P = .44). Minor nosebleed was the most common device-related adverse event, reported in 45 of 337 patients (13%) in the intervention group. The adverse event rate within 7 days was similar between groups. Conclusions and Relevance: Among patients with out-of-hospital cardiac arrest, trans-nasal evaporative intra-arrest cooling compared with usual care did not result in a statistically significant improvement in survival with good neurologic outcome at 90 days. Trial Registration: ClinicalTrials.gov Identifier: NCT01400373.Peer reviewedFinal Accepted Versio

European Registry of Cardiac Arrest – Study-THREE (EuReCa THREE) – an international, prospective, multi-centre, three-month survey of epidemiology, treatment and outcome of patients with out-of-hospital cardiac arrest in Europe – the study protocol

Background The aim of the European Registry of Cardiac Arrest (EuReCa) network is to provide high quality evidence on epidemiology of out-of-hospital cardiac arrest (OHCA) in Europe by supporting and developing cardiac arrest registries and performing European-wide studies. To date, the EuReCa ONE and EuReCa TWO studies have involved around 28 countries, with population covered increasing from the first to the second study. The aim of the EuReCa THREE study is to build on previous work and to support the promotion of quality data collection on OHCA throughout Europe. Methods/design EuReCa THREE will be the third prospective cohort study on epidemiology of OHCA and will involve around 30 European countries. The study will be conducted between 1st September and 30th November 2022. Data will be collected on cardiac arrest cases attended, resuscitation attempted, patient and cardiac arrest event characteristics and outcomes (including return of spontaneous circulation, status on hospital arrival and discharge). A particular focus for EuReCa THREE will be to describe key time intervals in OHCA management; time from call to EMS arrival on scene, time from cardiac arrest to start CPR, time from EMS arrival to delivery of patient to hospital. EuReCa THREE was registered with the German Registry of Clinical Trials Registration Number: DRKS00028591 searchable via WHO meta-registry (https://apps.who.int/trialsearch/). Discussion The EuReCa THREE study will increase our knowledge on longitudinal OHCA epidemiology and provide new knowledge on crucial time intervals in OHCA management in Europe. However, the primary aim of building a network to support quality data on OHCA, remains the central tenant of the EuReCa project

Chiral Perturbation Theory Beyond One Loop

The existing Chiral Perturbation Theory (ChPT) calculations at order $p^6$ are reviewed. The principles of ChPT and how they are used are introduced. The main part is a review of the two- and three-flavour full two-loop calculations and their comparison with experiment. We restrict the discussion to the mesonic purely strong and semileptonic sector. The review concludes by mentioning the existing results in finite volume, finite temperature and partially quenched ChPT.Comment: 66 pages, review article, some references added plus a few discussions extende

The SDSS-IV extended Baryon Oscillation Spectroscopic Survey : Luminous Red Galaxy Target Selection

We describe the algorithm used to select the Luminous Red Galaxy (LRG) sample for the extended Baryon Oscillation Spectroscopic Survey (eBOSS) of the Sloan Digital Sky Survey IV (SDSS-IV) using photometric data from both the SDSS and the Wide-Field Infrared Survey Explorer (WISE). LRG targets are required to meet a set of color selection criteria and have z-band and i-band MODEL magnitudes z <19.95 and 19.9 <i < 21.8, respectively. Our algorithm selects roughly 50 LRG targets per square degree, the great majority of which lie in the redshift range 0.6 <z <1.0 (median redshift 0.71). We demonstrate that our methods are highly effective at eliminating stellar contamination and lower-redshift galaxies. We perform a number of tests using spectroscopic data from SDSS-III/BOSS to determine the redshift reliability of our target selection and its ability to meet the science requirements of eBOSS. The SDSS spectra are of high enough signal-to-noise ratio that at least 89% of the target sample yields secure redshift measurements. We also present tests of the uniformity and homogeneity of the sample, demonstrating that it should be clean enough for studies of the large-scale structure of the universe at higher redshifts than SDSS-III/BOSS LRGs reached.Publisher PDFPeer reviewe